Arthur Peter Bertolino
Keine laufenden Positionen mehr
Profil
Arthur Peter Bertolino worked as a Senior Medical Director & Director-Dermatology at Pfizer Inc. from 2003 to 2007.
He then worked as the Chief Medical Officer & VP-Medical Affairs at Peplin, Inc. from 2007 to 2008.
From 2008 to 2013, he worked as the Vice President-Dermatology at Novartis Institutes for Biomedical Research, Inc. He later worked as the Chief Medical Officer & Executive Vice President at Revance Therapeutics, Inc. from 2014 to 2016.
In 2016, he started working as the President, Director & Chief Medical Officer at Innovation Pharmaceuticals, Inc. until 2019.
Dr. Bertolino received his undergraduate degree from Stony Brook University, his MBA from Stephen M.
Ross School of Business, and his doctorate from The Johns Hopkins University School of Medicine.
Ehemalige bekannte Positionen von Arthur Peter Bertolino
| Unternehmen | Position | Ende |
|---|---|---|
| INNOVATION PHARMACEUTICALS INC. | President | 19.12.2019 |
| REVANCE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.01.2016 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2013 |
Peplin, Inc.
 Peplin, Inc. Pharmaceuticals: MajorHealth Technology Peplin, Inc. develops drugs and pharmaceutical products. The company was founded by James Harrison Aylward in 1998 and is headquartered in Emeryville, CA. | Chief Tech/Sci/R&D Officer | 01.01.2008 |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | 01.01.2007 |
Ausbildung von Arthur Peter Bertolino
| Stony Brook University | Undergraduate Degree |
| Stephen M. Ross School of Business | Masters Business Admin |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| REVANCE THERAPEUTICS, INC. | Health Technology |
| INNOVATION PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Peplin, Inc.
Peplin, Inc. Pharmaceuticals: MajorHealth Technology Peplin, Inc. develops drugs and pharmaceutical products. The company was founded by James Harrison Aylward in 1998 and is headquartered in Emeryville, CA. | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
